Literature DB >> 17000739

Molecular epidemiology of VIM-4 metallo-beta-lactamase-producing Pseudomonas sp. isolates in Hungary.

Balázs Libisch1, Mónika Muzslay, Mária Gacs, János Minárovits, Márta Knausz, Joseph Watine, Gábor Ternák, Eva Kenéz, Ildikó Kustos, László Rókusz, Klára Széles, Boglárka Balogh, Miklós Füzi.   

Abstract

VIM metallo-beta-lactamase-producing serotype O11 or O12 Pseudomonas aeruginosa isolates infecting or colonizing 19 patients from seven hospitals in Hungary were characterized between October 2003 and November 2005. Macrorestriction analysis revealed the involvement of hospitals from three different towns in northwest Hungary in an outbreak caused by VIM-4-producing P. aeruginosa.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17000739      PMCID： PMC1693993          DOI： 10.1128/AAC.00300-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  [Are the prolonged carrier and interhospital clonal diffusion of serotype O12 multiresistant Pseudomonas aeruginosa connected?].

Authors: 
Journal:  Pathol Biol (Paris)       Date:  2001-10

3.  In70 of plasmid pAX22, a bla(VIM-1)-containing integron carrying a new aminoglycoside phosphotransferase gene cassette.

Authors:  M L Riccio; L Pallecchi; R Fontana; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital.

Authors:  Kyungwon Lee; Jong Back Lim; Jong Hwa Yum; Dongeun Yong; Yunsop Chong; June Myung Kim; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

5.  Isolation of an integron-borne blaVIM-4 type metallo-beta-lactamase gene from a carbapenem-resistant Pseudomonas aeruginosa clinical isolate in Hungary.

Authors:  Balázs Libisch; Mária Gacs; Károly Csiszár; Mónika Muzslay; László Rókusz; Miklós Füzi
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

6.  Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-beta-lactamases in gram-negative bacilli.

Authors:  Jing-Jou Yan; Jiunn-Jong Wu; Shu-Huei Tsai; Chin-Luan Chuang
Journal:  Diagn Microbiol Infect Dis       Date:  2004-05       Impact factor: 2.803

7.  Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland.

Authors:  Janusz Fiett; Anna Baraniak; Agnieszka Mrówka; Malgorzata Fleischer; Zuzanna Drulis-Kawa; Łukasz Naumiuk; Alfred Samet; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

8.  Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp.

Authors:  Dongeun Yong; Kyungwon Lee; Jong Hwa Yum; Hee Bong Shin; Gian Maria Rossolini; Yunsop Chong
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

9.  Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales.

Authors:  Fiona W Scott; Tyrone L Pitt
Journal:  J Med Microbiol       Date:  2004-07       Impact factor: 2.472

10.  Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001).

Authors:  Jan Patzer; Mark A Toleman; Lalitagauri M Deshpande; Wanda Kamińska; Danuta Dzierzanowska; Peter M Bennett; Ronald N Jones; Timothy R Walsh
Journal:  J Antimicrob Chemother       Date:  2004-01-28       Impact factor: 5.790
View more
  10 in total

Review 1.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

2.  Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests.

Authors:  Alexandra Loli; Leonidas S Tzouvelekis; Dimitra Gianneli; Eva Tzelepi; Vivi Miriagou
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

3.  Identification of the first VIM metallo-beta-lactamase-producing multiresistant Aeromonas hydrophila strain.

Authors:  Balázs Libisch; Christian G Giske; Bogáta Kovács; Tamás G Tóth; Miklós Füzi
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

4.  Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4.

Authors:  Patricia Lassaux; Daouda A K Traoré; Elodie Loisel; Adrien Favier; Jean-Denis Docquier; Jean Sébastien Sohier; Clémentine Laurent; Carine Bebrone; Jean-Marie Frère; Jean-Luc Ferrer; Moreno Galleni
Journal:  Antimicrob Agents Chemother       Date:  2010-12-13       Impact factor: 5.191

5.  Identification of two multidrug-resistant Pseudomonas aeruginosa clonal lineages with a countrywide distribution in Hungary.

Authors:  Balázs Libisch; Boglárka Balogh; Miklós Füzi
Journal:  Curr Microbiol       Date:  2008-10-23       Impact factor: 2.188

Review 6.  Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.

Authors:  Theodoros Karampatakis; Charalampos Antachopoulos; Athanassios Tsakris; Emmanuel Roilides
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-11       Impact factor: 3.267

7.  Escherichia coli ST471 Producing VIM-4 Metallo-β-Lactamase in Colombia.

Authors:  Ana Mercedes Rada; Adriana Correa; Eliana Restrepo; Cesar Capataz
Journal:  Microb Drug Resist       Date:  2022-01-04       Impact factor: 3.431

8.  Role of Imipenem-resistant metallo-beta-lactamase positive pseudomonas aeruginosa carriers in nosocomial infections.

Authors:  Babu K V Yogeesha; Amruta Kumari; Arun Kumar; Kumar K G Raghu
Journal:  J Nat Sci Biol Med       Date:  2013-01

9.  Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary.

Authors:  Dora Szabó; Julia Szentandrássy; Zsuzsa Juhász; Katalin Katona; Károly Nagy; László Rókusz
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-05-30       Impact factor: 3.944

10.  First Italian outbreak of VIM-producing Serratia marcescens in an adult polyvalent intensive care unit, August-October 2018: A case report and literature review.

Authors:  Maria Rosaria Iovene; Vincenzo Pota; Massimiliano Galdiero; Giusy Corvino; Federica Maria Di Lella; Debora Stelitano; Maria Beatrice Passavanti; Maria Caterina Pace; Aniello Alfieri; Sveva Di Franco; Caterina Aurilio; Pasquale Sansone; Vettakkara Kandy Muhammed Niyas; Marco Fiore
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.